Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Sisram Medical Ltd. ( (HK:1696) ) has shared an update.
Sisram Medical has scheduled a board meeting for 23 March 2026 to review and approve the group’s annual results for the financial year ended 31 December 2025. The board will also consider recommending a final dividend and may address other corporate matters, signaling an upcoming disclosure of financial performance and potential shareholder returns that will be closely watched by investors.
The announcement confirms the company’s standard governance timetable, aligning its reporting and dividend decision process with market expectations for a Hong Kong-listed issuer. Investors and other stakeholders will look to the forthcoming board decisions for insight into the group’s recent operating performance and capital allocation stance, including whether a final dividend will be proposed.
The most recent analyst rating on (HK:1696) stock is a Hold with a HK$4.50 price target. To see the full list of analyst forecasts on Sisram Medical Ltd. stock, see the HK:1696 Stock Forecast page.
More about Sisram Medical Ltd.
Sisram Medical Ltd. is an Israel-incorporated medical technology company listed in Hong Kong, operating through a group structure. The group focuses on medical and aesthetic solutions, and its governance is overseen by a board comprising executive, non-executive and independent non-executive directors, reflecting a typical listed-company corporate structure.
Average Trading Volume: 499,415
Technical Sentiment Signal: Sell
Current Market Cap: HK$1.79B
For a thorough assessment of 1696 stock, go to TipRanks’ Stock Analysis page.